Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/693ba2e3-b928-8004-920f-e506d7f76c92
(section)
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===== 【共同重點】 ===== * 多數注射型 GLP-1 RA/腸泌素促效劑採 逐步調升劑量以改善胃腸道耐受性（噁心等）。【TFDA｜Dosage】Saxenda 衛部菌疫輸字第001140號114.04.07 Rybelsus 衛部菌疫輸字第001171號114.05.22 * 與胰島素或磺醯脲類併用時，低血糖風險增加；仿單通常建議評估是否需要降低胰島素/磺醯脲劑量（概念性管理，非個案醫囑）。【TFDA｜Warnings】Mounjaro 衛部藥輸字第028468號114.05.21
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
